CHEMOS
P-LysoPC

P-LysoPC

Nom chimique

1-Palmitoyl-sn-glycero-3-phosphocholine

P-LysoPC•LNP
Structure: P-LysoPC structure, CAS 17364-16-8, MW 495.63
N° produit
CH51034
CAS
17364-16-8
FM
C24H50NO7P
PM
495.63
Spécification
Catalog No.CH51034
CAS No.17364-16-8
Molecular FormulaC24H50NO7P
Molecular Weight495.63

CHEMOS Support for This Category

CHEMOS supports custom synthesis and process development for LNP lipid components, with work planned according to target structure, requested scale, and analytical requirements. Ionizable lipid route development : route scouting, impurity review, stereochemistry control, and purification planning. Helper lipid and PEG-lipid preparation : support for phospholipids, sterol-related components, PEG-lipids, and related analogs. Analytical support : HPLC, NMR, MS, Karl Fischer water content, elemental analysis, and residual-solvent testing can be discussed by project. Scale-up support : transfer from laboratory preparation to larger pilot or production batches after route and quality review. Project documentation : batch-specific COA and technical information are provided according to the confirmed specification.

Vue d’ensemble

P-LysoPC (also known as 1-Palmitoyl-sn-glycero-3-phosphocholine) (CAS 17364-16-8, MF C24H50NO7P, MW 495.63) belongs to the helper phospholipid class used in nucleic acid delivery system research and liposomal drug carriers. Typical chemistry topics include stereo-purity at the glycerol backbone, residual free fatty acid, and related diacyl regio-isomers. Project scale-up and custom synthesis are coordinated by the CHEMOS R&D team across laboratory and production sites.

Applications

  • P-LysoPC (17364-16-8) as a starting point for downstream chemistry programs
  • Process-development support for scalable phospholipid preparation
  • Reference material in liposome composition optimisation studies
  • Helper phospholipid component in LNP and liposomal formulation research

Besoin d’une synthèse à façon ?

Notre équipe CDMO accompagne la synthèse à façon, de l’évaluation de voie au développement de procédé et au scale-up.

Voir les services CDMO